Completed PHASE4 INTERVENTIONAL 2-arm
NCT06664138
Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment
Sponsor: Yeongseok Yun
Interventions
Etomidate Remimazolam
Updated 2 times since 2024 Last updated: Oct 29, 2024 Started: Apr 28, 2023 Primary completion: Jan 31, 2024 Completion: Jan 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Bipolar and Major Depression Disorders, this trial is completed. The trial is conducted by Yeongseok Yun and has accumulated 2 data snapshots since 2023. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
2 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Nov 2024 — Sep 2025 [monthly]
Completed PHASE4
First recorded
Apr 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Yeongseok Yun
Data source: Dankook University
For direct contact, visit the study record on ClinicalTrials.gov .